Novo Nordisk stock

2024 - 12 - 20

Novo Nordisk Novo Nordisk

Post cover
Image courtesy of "CNBC"

Novo Nordisk shares plunge 20% after disappointing trial results ... (CNBC)

Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point on Friday after reporting trial results that missed expectations.

Post cover
Image courtesy of "Barron's"

Novo Nordisk Stock Crashes on Obesity Drug Data. It's a Win for Eli ... (Barron's)

Novo Nordisk stock fell sharply after the Ozempic maker's experimental obesity drug CagriSema disappointed investors. Eli Lilly Shares Soar.

Post cover
Image courtesy of "Reuters"

Novo Nordisk shares plunge after CagriSema obesity drug trial ... (Reuters)

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema, wiping as much as ...

Post cover
Image courtesy of "FierceBiotech"

Novo stock crashes after CagriSema misses weight-loss goal (FierceBiotech)

A phase 3 trial of Novo Nordisk's next-generation obesity prospect CagriSema has failed to achieve the level of weight loss targeted by executives, ...

Post cover
Image courtesy of "Financial Times"

Novo Nordisk shares tumble as weight-loss drug trial data disappoints (Financial Times)

Novo Nordisk's shares fell sharply on Friday as disappointing results from tests of its latest obesity drug wiped about €90bn off the valuation of Europe's ...

Post cover
Image courtesy of "Morningstar"

Novo Nordisk Stock Crashes After Disappointing Obesity Drug Data (Morningstar)

Shares of the pharmaceutical giant plummeted 28% after a late-stage weight loss drug trial missed expectations.

Post cover
Image courtesy of "The Wall Street Journal"

Why Novo Nordisk's Stock Plunge Is Rattling Markets (The Wall Street Journal)

Shares in Ozempic maker Novo Nordisk fell sharply, after an experimental anti-obesity shot fell short of expectations. The shares recently stood about 20% ...

Post cover
Image courtesy of "Fortune"

Novo Nordisk faces stock market bloodbath after weight-loss drug ... (Fortune)

Shares in Novo Nordisk plunged 20% on Friday. Victor Golmer—Getty Images. Novo Nordisk, Europe's largest company by market value, ...

Post cover
Image courtesy of "Investor's Business Daily"

Novo Crashes 20% After Next-Gen Obesity Drug Misses (Investor's Business Daily)

Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly anticipated study.

Post cover
Image courtesy of "Motley Fool"

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and ... (Motley Fool)

Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.

Post cover
Image courtesy of "Morningstar.com"

Novo Nordisk Stock Plunges After Disappointing Obesity Drug Data (Morningstar.com)

Shares of the pharmaceutical giant fell 20% after a late-stage weight-loss drug trial missed expectations.

Explore the last week